Immunological Methods a compendium of basic research techniques being used in one of the largest immunology research institutes, the Basel Institute for Immunology, with particular emphasis given to new methodology. The procedures have been described by individuals judged to be highly expert in their specialties. In many instances the methods developed or adapted to unique uses by the contributors have not previously been described in detail. The book contains 34 chapters covering techniques for detection, isolation, and purification of antibodies (including dansylation, two-dimensional chromatography, isoelectric focusing, polyacrylamide gel electrophoresis, and isotachophoresis); measurement of equilibrium constants (equilibrium dialysis, filtration, and sedimentation); and isotope and fluorescent labeling and detection of cell-surface components. Techniques such as isotope laboratory maintenance; chemical modification of proteins, haptens, and solid supports, and haptenation of viable biological carriers; production of antisera against allotypes and histocompatibility antigens and production of antibody with clonai dominance; histocompatibility and MLR testing; and cell separation by haptenated gels and by velocity sedimentation of rosette-forming cells are also discussed. Other chapters cover detection of antibody-secreting and alloantigen-binding cells; immune responses in vitro and their analysis by limiting dilution; production of T-cell factors; hybridoma production by cell fusion; maintenance of cell lines and cloning in semisolid media; and the mathematical analysis of immunological data.
Inhaltsverzeichnis
1;Front Cover;1 2;Immunological Methods;4 3;Copyright Page;5 4;Table of Contents;6 5;List of Contributors;16 6;Preface;18 7;Abbreviations List;22 8;Chapter 1. The Quality of Antibodies and Cellular Receptors;26 8.1;I. INTRODUCTION;26 8.2;II. SIMPLE EQUILIBRIA;27 8.3;III. COMPETITIVE EQUILIBRIA;55 8.4;REFERENCES;66 9;Chapter 2. The Isolation and Characterization of Immunoglobulins, Antibodies, and Their Constituent Polypeptide Chains;68 9.1;I. INTRODUCTION;69 9.2;II. FRACTIONATION WITH NEUTRAL SALTS AT HIGH CONCENTRATION;69 9.3;III. PURIFICATION OF Ig's;70 9.4;IV. FRACTIONATION BY GEL FILTRATION CHROMATOGRAPHY;72 9.5;V. ELECTROPHORETIC SEPARATION ON A SOLID SUPPORTING MEDIUM;73 9.6;VI. ISOLATION OF ANTIBODY BY AFFINITY CHROMATOGRAPHY ON SEPHAROSE IMMUNOADSORBENTS;76 9.7;VII. IMMUNOADSORBENTS WITH INSOLUBILIZED GLUTARALDEHYDE-TREATED PROTEINS;83 9.8;VIII. SEPARATION OF POLYPEPTIDE CHAINS;85 9.9;IX. USE OF PROTEIN A FROM Staphylococcus aureus AS AN IMMUNOADSORBENT FOR THE ISOLATION OF Ig's;87 9.10;ACKNOWLEDGMENTS;91 9.11;REFERENCES;91 10;Chapter 3. Peptide Mapping at the Nanomole Level;94 10.1;I. OBJECTIVE;94 10.2;II. PRINCIPLE OF THE METHOD;95 10.3;III. MATERIALS;95 10.4;IV. PROCEDURE;97 10.5;V. CRITICAL APPRAISAL;100 10.6;VI. AN EXAMPLE OF THE APPLICATION OF THE METHOD TO ANTIGENIC VARIANTS OF INFLUENZA-A VIRUS HEMAGGLUTININ;102 10.7;REFERENCES;104 11;Chapter 4. Electrophoresis of Proteins in Polyacrylamide Slab Gels;106 11.1;I. INTRODUCTION;106 11.2;II. PROCEDURES FOR POLYACRYLAMIDE GEL ELECTROPHORESIS;107 11.3;III. CONCLUSION;129 11.4;REFERENCES;129 12;Chapter 5. Resolution of Immunoglobulin Patterns by Analytical Isoelectric Focusing;132 12.1;I. INTRODUCTION;132 12.2;II. PRINCIPLE OF THE METHOD;133 12.3;III. MATERIALS;133 12.4;IV. PROCEDURES;134 12.5;V. APPLICATION, SENSITIVITY, AND REPRODUCIBILITY OF IEF;142 12.6;REFERENCES;145 13;Chapter 6. Isolation of Monoclonal Antibody by Preparative Isoelectric Focusing in Horizontal Layers of Sephadex G-75;148 13.1;I. INTR
ODUCTION;148 13.2;II. PRINCIPLE OF THE METHOD;149 13.3;III. MATERIAL;150 13.4;IV. PROCEDURE;151 13.5;V. APPLICATIONS;153 13.6;VI. LIMITATIONS;153 13.7;VII. DEGREE OF PURIFICATION AND SENSITIVITY;155 13.8;VIII. REPRODUCIBILITY;155 13.9;ACKNOWLEDGMENT;155 13.10;REFERENCES;155 14;Chapter 7. Isotachophoresìs of Immunoglobulins;156 14.1;1. INTRODUCTION;156 14.2;II. PROCEDURE;157 14.3;III. DISCUSSION;160 14.4;REFERENCES;161 15;Chapter 8. The Chemical Modification of Proteins, Haptens, and Solid Supports;162 15.1;I. INTRODUCTION;162 15.2;II. THEORETICAL BACKGROUND;163 15.3;III. EXPERIMENTATION;170 15.4;SUGGESTED READING;175 15.5;REFERENCES;175 16;Chapter 9. Reagents for Immunofluorescence and Their Use for Studying Lymphoid Cell Products;176 16.1;I. INTRODUCTION;176 16.2;II. REAGENTS FOR IMMUNOFLUORESCENCE;178 16.3;III. STAINING PROCEDURES;185 16.4;IV. GENERAL COMMENTS;190 16.5;SUGGESTED READING;191 16.6;REFERENCES;191 17;Chapter 10. Radiolab eling and Immunoprecipitation of Cell-Surface Macromolecules;194 17.1;I. INTRODUCTION;194 17.2;II. LABELING PROCEDURES;195 17.3;III. LYSIS OF LABELED CELLS;200 17.4;IV. SPECIFIC PURIFICATION OF LABELED CELL-SURFACE COMPONENTS;201 17.5;REFERENCES;203 18;Chapter 11. Haptenation of Viable Biological Carriers;206 18.1;I. INTRODUCTION;206 18.2;II. PREPARATION OF ONS ESTERS;210 18.3;III. HAPTENATION OF CARRIERS;214 18.4;IV. CML CULTURE CONDITIONS;215 18.5;V. OBSERVATIONS ON CML RESPONSES TO HAPTENATED LYMPHOCYTES;219 18.6;ACKNOWLEDGMENT;219 18.7;REFERENCES;219 19;Chapter 12. Production and Assay of Murine Anti-Allotype Antisera;222 19.1;1. PRODUCTION OF ANTI-ALLOTYPE SERUM;224 19.2;II. QUANTITATION OF ANTI-ALLOTYPE SERUM;226 19.3;III. APPLICATIONS;231 19.4;REFERENCES;231 20;Chapter 13. Preparation of Mouse Antisera against Histocompatibility Antigens;232 20.1;I. OBJECTIVE;232 20.2;II. PRINCIPLE OF THE METHOD;233 20.3;III. MATERIALS AND PROCEDURE;233 20.4;IV. CONTROLS;239 20.5;V. CRITICAL APPRAISAL;240 20.6;REFERENCES;241 21;Chapter 14. Tech
nique of HLA Typing by Complement-Dependent Lympholysis;242 21.1;I. INTRODUCTION;242 21.2;II. PRINCIPLES OF THE TEST;243 21.3;III. DETAILS OF THE TEST;244 21.4;IV. FAMILY STUDIES;247 21.5;V. SOME COMMENTS ON THE CYTOTOXICITY TEST;247 21.6;VI. TECHNIQUE FOR DETECTING B-CELL ANTIGENS OF THE HLA SYSTEM;250 21.7;REFERENCES;251 22;Chapter 15. The MLR Test in the Mouse;252 22.1;I. THE CONVENTIONAL PRIMARY MLR;252 22.2;II. IN VITRO SECONDARY MLR;260 22.3;III. CRITICAL COMMENTS;262 22.4;ACKNOWLEDGMENT;263 22.5;REFERENCES;263 23;Chapter 16. Sensitive Method for the Separation of Rosette-Forming Cells;266 23.1;I. OBJECTIVE;267 23.2;II. PRINCIPLE OF THE METHOD;267 23.3;III. FORMATION OF ROSETTES;267 23.4;IV. CELL FRACTIONATION;269 23.5;V. RECOVERY, DEPLETION, AND ENRICHMENT;275 23.6;VI. APPLICATIONS, SENSITIVITY, AND LIMITATIONS;277 23.7;VII. CONCLUSION;283 23.8;ACKNOWLEDGMENTS;283 23.9;REFERENCES;284 24;Chapter 17. The Use of Protein A Rosettes to Detect Cell-Surface Antigens;286 24.1;I. INTRODUCTION;286 24.2;II. PRINCIPLE OF THE METHOD;287 24.3;III. MATERIALS;287 24.4;IV. PROCEDURES;288 24.5;V. CONTROLS;290 24.6;VI. CRITICAL ASPECTS;290 24.7;VII. APPLICATIONS;291 24.8;REFERENCES;292 25;Chapter 18. Hapten-Gelatin Gels Used as Adsorbents for Separation of Hapten-Specific B Lymphocytes;294 25.1;I. PRINCIPLE;294 25.2;II. DESCRIPTION OF THE TECHNIQUE;295 25.3;III. APPLICATIONS;299 25.4;IV. LIMITATIONS;300 25.5;REFERENCES;300 26;Chapter 19. Assay for Plaque-Forming Cells;302 26.1;I. OBJECTIVE;302 26.2;II. PRINCIPLE OF THE METHOD;302 26.3;III. MATERIAL;303 26.4;IV. PREPARATION OF CELL SUSPENSIONS;304 26.5;V. PLAQUING PROCEDURES;305 26.6;VI. CALCULATIONS;307 26.7;VII. CRITICAL FACTORS;307 26.8;REFERENCES;309 27;Chapter 20. Plaquing and Recovery of Individual Antibody-Producing Cells;312 27.1;I. OBJECTIVE;312 27.2;II. MATERIALS;313 27.3;III. PROCEDURE;313 27.4;REFERENCES;315 28;Chapter 21. Assay for Specific Alloantigen-Binding T Cells Activated in the Mixed Lymphocyte Reaction;316 2
8.1;I. OBJECTIVE;317 28.2;II. PRINCIPLE OF THE METHOD;317 28.3;III. CELLS AND ALLOANTISERA;317 28.4;IV. DETECTION OF T-CELL MARKERS AND STIMULATOR ANTIGENS ON RESPONDER BLASTS;321 28.5;V. ASSAY FOR ALLOANTIGEN-BINDING CELLS;325 28.6;VI. CRITICAL APPRAISAL: APPLICATIONS AND LIMITATIONS;327 28.7;VII. CONCLUSION;332 28.8;ACKNOWLEDGMENTS;332 28.9;REFERENCES;333 29;Chapter 22. Assay for Antigen-Specific T-Cell Proliferation in Mice;334 29.1;I. OBJECTIVE;334 29.2;II. PRINCIPLE OF THE METHOD;335 29.3;III. MATERIALS;335 29.4;IV. PROCEDURE;336 29.5;V. CRITICAL APPRAISAL;339 29.6;ACKNOWLEDGMENT;340 29.7;REFERENCES;340 29.8;NOTE ADDED IN PROOF;340 30;Chapter 23. Antigen-Specific Helper T-Cell Factor and Its Acceptor;342 30.1;I. INTRODUCTION;342 30.2;II. PRINCIPLE OF THE METHOD;343 30.3;III. MATERIALS;344 30.4;IV. PROCEDURE;344 30.5;V. CALCULATIONS;347 30.6;VI. CRITICAL APPRAISAL;347 30.7;REFERENCES;350 31;Chapter 24. In Vitro Immunization of Dissociated Murine Spleen Cells;352 31.1;I. OBJECTIVE;352 31.2;II. PRINCIPLE OF THE METHOD;353 31.3;III. MATERIALS;353 31.4;IV. PROCEDURE;355 31.5;V. CRITICAL APPRAISAL;357 31.6;REFERENCES;359 32;Chapter 25. Induction of a Secondary Antibody Response in Vitro with Rabbit Peripheral Blood Lymphocytes;360 32.1;I. OBJECTIVE;360 32.2;II. PRINCIPLE OF THE METHOD;361 32.3;III. MATERIALS;361 32.4;IV. PROCEDURE;363 32.5;V. COMMENTS;367 32.6;REFERENCES;368 33;Chapter 26. Induction of Immune Responses with Clonal Dominance at High Antibody Levels;370 33.1;I. INTRODUCTION;370 33.2;II. PRINCIPLE OF THE METHOD;372 33.3;III. VACCINE PREPARATION;372 33.4;IV. IMMUNIZATION;373 33.5;V. SERIAL TRANSFER OF LIMITED SPLEEN CELL NUMBERS;376 33.6;VI. CRITICAL APPRAISAL;377 33.7;SUGGESTED READING;377 33.8;REFERENCES;378 34;Chapter 27. Limiting Dilution Analysis;380 34.1;I. OBJECTIVE;381 34.2;II. PRINCIPLE OF THE METHOD;381 34.3;III. MATERIALS;381 34.4;IV. METHODS (FIG. 3, FLOW DIAGRAM);385 34.5;V. LIMITATIONS AND SENSITIVITY;392 34.6;SUGGESTED READING;395 34.7;REF
ERENCES;395 35;Chapter 28. Establishment and Maintenance of Murine Lymphoid Cell Lines in Culture;396 35.1;I. OBJECTIVE;396 35.2;II. PRINCIPLE OF THE METHOD;397 35.3;III. MATERIALS;398 35.4;IV. PROCEDURE;399 35.5;V. CRITICAL APPRAISAL;402 35.6;SUGGESTED READING;403 35.7;REFERENCES;403 36;Chapter 29. Clonal Growth of Cells in Semisolid or Viscous Medium;404 36.1;I. INTRODUCTION;404 36.2;II. MATERIALS;405 36.3;III. PROCEDURE;406 36.4;IV. APPLICATIONS;408 36.5;SUGGESTED READING;409 36.6;REFERENCES;409 37;Chapter 30. Preparation of Sendai Virus for Cell Fusion;412 37.1;I. GROWTH OF VIRUS;412 37.2;II. TITRATION OF VIRUS;413 37.3;III. CONCENTRATION OF VIRUS;414 37.4;IV. INACTIVATION OF VIRUS;414 37.5;V. ASSAY OF INFECTIVITY;415 37.6;REFERENCES;415 38;Chapter 31. Fusion of Lymphocytes;416 38.1;I. OBJECTIVE;416 38.2;II. PRINCIPLE OF THE METHOD;416 38.3;III. MATERIAL;417 38.4;IV. PROCEDURE;417 38.5;V. CRITICAL APPRAISAL;419 38.6;REFERENCES;420 39;Chapter 32. Soft Agar Cloning of Lymphoid Tumor Lines: Detection of Hybrid Clones with Anti-SRBC Activity;422 39.1;I. OBJECTIVE AND PRINCIPLE OF THE METHOD;422 39.2;II. MATERIAL;422 39.3;III. PROCEDURE;423 39.4;V. CRITICAL APPRAISAL;423 39.5;REFERENCES;426 40;Chapter 33. Isotope Laboratory;428 40.1;I. INTRODUCTION;428 40.2;II. MATERIALS;429 40.3;III. SPECIAL PROCEDURES;431 40.4;IV. RADIATION AND CONTAMINATION SURVEILLANCE;437 40.5;ACKNOWLEDGMENTS;442 40.6;SUGGESTED READING;442 40.7;REFERENCES;442 41;Chapter 34. Analysis of Immunological Data;444 41.1;I. INTRODUCTION;445 41.2;II. WORKED EXAMPLES;445 41.3;ACKNOWLEDGMENTS;480 41.4;REFERENCES;480 42;Subject Index;482